<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>1688-1249</journal-id>
<journal-title><![CDATA[Archivos de Pediatría del Uruguay]]></journal-title>
<abbrev-journal-title><![CDATA[Arch. Pediatr. Urug.]]></abbrev-journal-title>
<issn>1688-1249</issn>
<publisher>
<publisher-name><![CDATA[Sociedad Uruguaya de Pediatría]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S1688-12492025000301209</article-id>
<article-id pub-id-type="doi">10.31134/ap.96.21</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Monitorización de variables metabólicas en niñas, niños y adolescentes hospitalizados en el Centro Hospitalario Pereira Rossell que utilizan antipsicóticos atípicos]]></article-title>
<article-title xml:lang="en"><![CDATA[Monitoring of metabolic variables in children and adolescents who use atypical antipsychotics assisted at the Pereira Rossell Pediatric Hospital Center]]></article-title>
<article-title xml:lang="pt"><![CDATA[Monitorado de variáveis metabólicas em crianças e adolescentes que utilizam antipsicóticos atípicos atendidos no Centro Hospitalar Pereira Rossell]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Cabral]]></surname>
<given-names><![CDATA[Santiago]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Zunino]]></surname>
<given-names><![CDATA[Carlos]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Catenaccio]]></surname>
<given-names><![CDATA[Valentina]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Vergara]]></surname>
<given-names><![CDATA[María José]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Castellanos]]></surname>
<given-names><![CDATA[Paula]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Cerdeña]]></surname>
<given-names><![CDATA[Eliana]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Fernández]]></surname>
<given-names><![CDATA[Carolina]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Gottero]]></surname>
<given-names><![CDATA[Manuela]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Martínez]]></surname>
<given-names><![CDATA[Julia]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Sena]]></surname>
<given-names><![CDATA[Agustina]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Giachetto]]></surname>
<given-names><![CDATA[Gustavo]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Speranza]]></surname>
<given-names><![CDATA[Noelia]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,UDELAR Facultad de Medicina Unidad Académica de Farmacología y Terapéutica]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>Uruguay</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,UDELAR Facultad de Medicina Unidad Académica de Pediatría C]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>Uruguay</country>
</aff>
<aff id="Af3">
<institution><![CDATA[,UDELAR Facultad de Medicina ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>Uruguay</country>
</aff>
<aff id="Af4">
<institution><![CDATA[,UDELAR Facultad de Medicina Unidad Académica de Métodos Cuantitativos]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>Uruguay</country>
</aff>
<aff id="Af5">
<institution><![CDATA[,UDELAR Facultad de Medicina ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>Uruguay</country>
</aff>
<aff id="Af6">
<institution><![CDATA[,UDELAR Facultad de Medicina Unidad Académica de Pediatría C]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>Uruguay</country>
</aff>
<aff id="Af7">
<institution><![CDATA[,UDELAR Facultad de Medicina Unidad Académica de Farmacología y Terapéutica]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>Uruguay</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>00</month>
<year>2025</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>00</month>
<year>2025</year>
</pub-date>
<volume>96</volume>
<numero>2</numero>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.edu.uy/scielo.php?script=sci_arttext&amp;pid=S1688-12492025000301209&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.edu.uy/scielo.php?script=sci_abstract&amp;pid=S1688-12492025000301209&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.edu.uy/scielo.php?script=sci_pdf&amp;pid=S1688-12492025000301209&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen:  Introducción:  el consumo de psicofármacos, particularmente los antipsicóticos, ha ido en aumento a nivel global en niñas, niños y adolescentes (NNA). En Uruguay existen pocos estudios al respecto, pero también evidencian un uso elevado. Los antipsicóticos atípicos se asocian a alteraciones metabólicas como dislipidemia, diabetes, sobrepeso/obesidad, entre otros.  Objetivos:  describir variables metabólicas clínicas y paraclínicas en NNA que usan antipsicóticos atípicos, ingresados en salas de cuidados moderados del Centro Hospitalario Pereira Rossell (CHPR), en el período de julio - setiembre de 2022.  Metodología:  se realizó un estudio observacional, transversal, descriptivo, que incluyó pacientes de entre 2-15 años de edad y se obtuvieron datos farmacológicos, antropométricos y bioquímicos. Se evaluó la actividad física y la calidad de alimentación. Se utilizó el software estadístico PSPP versión 3. El estudio fue aprobado por el Comité de Ética de Investigación del CHPR.  Resultados:  fueron incluidos 53 NNA con una mediana de edad de 13 años. Risperidona, quetiapina y aripiprazol fueron los más usados. Treinta por ciento presentaba sobrepeso/obesidad, 50% era sedentario y 30% presentaba hábitos alimenticios de riesgo. Veintiún NNA contaban con la bioquímica sanguínea recomendada para monitorizar a los usuarios de estos fármacos.  Conclusiones:  se halló alguna alteración metabólica en más de la mitad de los sujetos incluidos. Risperidona se mantiene como el antipsicótico más prescrito en esta población, existiendo un uso creciente de aripiprazol. La polifarmacia persistió como un problema de la prescripción en estos pacientes.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Summary:  Introduction:  the consumption of psychotropic drugs, particularly antipsychotics, has been increasing globally in children and adolescents (NNA). In our country, there are few studies on the subject, but they show a high level of use of these drugs. Atypical antipsychotics are associated with metabolic alterations such as dyslipidemia, diabetes, and overweight/obesity, among others.  Objectives:  describe clinical and paraclinical metabolic variables in NNA using atypical antipsychotics, admitted to moderate care wards at the Pereira Rossell Hospital Center, during the period of July - September 2022.  Methodology:  an observational, cross-sectional, descriptive study was conducted, including patients aged 2-15 years. Pharmacological, anthropometric, and biochemical data were obtained. Physical activity and dietary quality were evaluated. The PSPP statistical software version 3 was used. The study was approved by the Research Ethics Committee of the Pereira Rossell Hospital Center (CHPR).  Results:  fifty-three NNA were included, with a median age of 13 years. Risperidone, quetiapine, and aripiprazol were the most commonly used. Thirty percent presented overweight/obesity, 50% were sedentary, and 30% had unhealthy eating habits. Twenty-one NNA had had the recommended blood biochemichal tests used to monitor these drug users.  Conclusions:  metabolic alterations were found in more than half of the included subjects. Risperidone remains the most prescribed antipsychotic in this population, with a growing use of aripiprazol. Polypharmacy persisted as a prescription problem in these patients.]]></p></abstract>
<abstract abstract-type="short" xml:lang="pt"><p><![CDATA[Resumo:  Introdução:  o consumo de psicofármacos, particularmente os antipsicóticos, tem vindo a aumentar a nível global em crianças e adolescentes (NNA). No nosso país, existem poucos estudos sobre o assunto, mas eles também evidenciam um uso elevado. Os antipsicóticos atípicos estão associados a alterações metabólicas como dislipidemia, diabetes, sobrepeso/obesidade, entre outras.  Objetivos:  descrever variáveis metabólicas clínicas e paraclínicas em NNA que utilizam antipsicóticos atípicos, internados em enfermarias de cuidados moderados do Centro Hospitalar Pereira Rossell, no período de julho a setembro de 2022.  Metodologia:  realizou-se um estudo observacional, transversal, descritivo, que incluiu pacientes com idades entre 2 e 15 anos. Foram obtidos dados farmacológicos, antropométricos e bioquímicos. A atividade física e a qualidade da alimentação foram avaliadas. Foi utilizado o software estatístico PSPP versão 3. O estudo foi aprovado pelo Comitê de Ética em Pesquisa do Centro Hospitalar Pereira Rossell (CHPR).  Resultados:  foram incluídos 53 NNA, com uma idade mediana de 13 anos. Risperidona, quetiapina e aripiprazol foram os mais utilizados. Trinta por cento apresentavam sobrepeso/obesidade, 50% eram sedentários e 30% apresentavam hábitos alimentares de risco. Vinte e um NNA tinham a bioquímica sanguínea recomendada para monitorar os usuários desses fármacos.  Conclusões:  foi encontrada alguma alteração metabólica em mais da metade dos sujeitos incluídos. A risperidona mantém-se como o antipsicótico mais prescrito nesta população, existindo um uso crescente de aripiprazol. A polifarmácia persistiu como um problema da prescrição nestes pacientes.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[Antipsicóticos]]></kwd>
<kwd lng="es"><![CDATA[Niño]]></kwd>
<kwd lng="es"><![CDATA[Adolescente]]></kwd>
<kwd lng="en"><![CDATA[Antipsychotic Agents]]></kwd>
<kwd lng="en"><![CDATA[Child]]></kwd>
<kwd lng="en"><![CDATA[Adolescent]]></kwd>
<kwd lng="pt"><![CDATA[Antipsicóticos]]></kwd>
<kwd lng="pt"><![CDATA[Criança]]></kwd>
<kwd lng="pt"><![CDATA[Adolescente]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Alessi]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Biscontri]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Collins]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Sareen]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Enns]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Ten years of antipsychotic prescribing to children a Canadian population-based study]]></article-title>
<source><![CDATA[Can J Psychiatry]]></source>
<year>2012</year>
<volume>57</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>52-8</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gatell]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[García]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Vedia]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Bruna]]></surname>
<given-names><![CDATA[X]]></given-names>
</name>
<name>
<surname><![CDATA[Morales]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Gómez]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Uso de psicofármacos en población pediátrica europea]]></article-title>
<source><![CDATA[Rev Pediatr Aten Primaria]]></source>
<year>2020</year>
<volume>22</volume>
<numero>28</numero>
<issue>28</issue>
<page-range>46</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mastroianni]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Ackermann]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Speranza]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Catenaccio]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Telechea]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Giachetto]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Características del uso de psicofármacos en niños hospitalizados]]></article-title>
<source><![CDATA[Arch Pediatr Urug]]></source>
<year>2017</year>
<volume>88</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>132-41</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Barrios]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Barrios]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Behrens]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Bentos]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Di Caterina]]></surname>
<given-names><![CDATA[X]]></given-names>
</name>
<name>
<surname><![CDATA[Maurente]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Politerapia en niños y adolescentes hospitalizados en cuidados moderados en el Hospital Pediátrico del Centro Hospitalario Pereira Rossell (julio-setiembre 2019)]]></article-title>
<source><![CDATA[Arch Pediatr Urug]]></source>
<year>2020</year>
<volume>91</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>207-24</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="book">
<collab>Asociación Española de Pediatría</collab>
<collab>Comité de Medicamentos</collab>
<source><![CDATA[Pediamécum: Aripiprazol]]></source>
<year>2021</year>
<publisher-loc><![CDATA[Madrid ]]></publisher-loc>
<publisher-name><![CDATA[AEP]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="book">
<collab>Asociación Española de Pediatría</collab>
<collab>Comité de Medicamentos</collab>
<source><![CDATA[Pediamécum: Risperidona]]></source>
<year>2020</year>
<publisher-loc><![CDATA[Madrid ]]></publisher-loc>
<publisher-name><![CDATA[AEP]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pillinger]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[McCutcheon]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Vano]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Mizuno]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Arumuham]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Hindley]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Comparative effects of 18 antipsychotics on metabolic function in patients with schizophrenia, predictors of metabolic dysregulation, and association with psychopathology a systematic review and network meta-analysis]]></article-title>
<source><![CDATA[Lancet Psychiatry]]></source>
<year>2020</year>
<volume>7</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>64-77</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pozzi]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Ferrentino]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Scrinzi]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Scavone]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Capuano]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Radice]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Weight and body mass index increase in children and adolescents exposed to antipsychotic drugs in non-interventional settings a meta-analysis and meta-regression]]></article-title>
<source><![CDATA[Eur Child Adolesc Psychiatry]]></source>
<year>2022</year>
<volume>31</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>21-37</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Nicol]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Yingling]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Flavin]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Schweiger]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Patterson]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Schechtman]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Metabolic effects of antipsychotics on adiposity and insulin sensitivity in youths a randomized clinical trial]]></article-title>
<source><![CDATA[JAMA Psychiatry]]></source>
<year>2018</year>
<volume>75</volume>
<numero>8</numero>
<issue>8</issue>
<page-range>788-96</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Whicher]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Price]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Holt]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Mechanisms in endocrinology antipsychotic medication and type 2 diabetes and impaired glucose regulation]]></article-title>
<source><![CDATA[Eur J Endocrinol]]></source>
<year>2018</year>
<volume>178</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>R245-58</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Delacrétaz]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Vandenberghe]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Glatard]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Dubath]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Levier]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Gholam]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Lipid disturbances in adolescents treated with second-generation antipsychotics clinical determinants of plasma lipid worsening and new-onset hypercholesterolemia]]></article-title>
<source><![CDATA[J Clin Psychiatry]]></source>
<year>2019</year>
<volume>80</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>18m12414</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sjo]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Stenstrøm]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Bojesen]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Frølich]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Bilenberg]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Development of metabolic syndrome in drug-naive adolescents after 12 months of second-generation antipsychotic treatment]]></article-title>
<source><![CDATA[J Child Adolesc Psychopharmacol]]></source>
<year>2017</year>
<volume>27</volume>
<numero>10</numero>
<issue>10</issue>
<page-range>884-91</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="">
<collab>Comisión Honoraria para la Salud Cardiovascular</collab>
<source><![CDATA[Enfermedades cardiovasculares. Semana del Corazón]]></source>
<year>2022</year>
</nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Tabárez]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Köncke]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Borrat]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Pérez]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Areal]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Méndez]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Obesidad e insulinorresistencia en un grupo de niños que se asisten en el Centro Hospitalario Pereira Rossell]]></article-title>
<source><![CDATA[Arch Pediatr Urug]]></source>
<year>2007</year>
<volume>78</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>59</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Graña]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Burgueño]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Olivera]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Casella]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Cáceres]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Piquerez]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Primer trabajo comunitario de prevención cardiovascular en pediatría en Lascano]]></article-title>
<source><![CDATA[Arch Pediatr Urug]]></source>
<year>2009</year>
<volume>80</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>77-89</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Estragó]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Tabárez]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Muñóz]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[González]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Bulla]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Díaz]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Sobrepeso, obesidad e hipertensión arterial en niños, una aproximación al problema]]></article-title>
<source><![CDATA[Arch Pediatr Urug]]></source>
<year>2018</year>
<volume>89</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>301-10</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bove]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Giachetto]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Ramírez]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Zelmonovich]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Guillermo]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Klaps]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Sobrepeso, obesidad y niveles de presión arterial en niños de nivel 5 de jardines de infantes públicos de Montevideo prevalencia y factores asociados]]></article-title>
<source><![CDATA[Rev Méd Urug]]></source>
<year>2020</year>
<volume>36</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>254-66</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Assandri]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Casuriaga]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Le Pera]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Notejane]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Vázquez]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Zunino]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<source><![CDATA[Atención pediátrica: normas nacionales de diagnóstico, tratamiento y prevención]]></source>
<year>2020</year>
<edition>9</edition>
<publisher-loc><![CDATA[Montevideo ]]></publisher-loc>
<publisher-name><![CDATA[Oficina del Libro-FEFMUR]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Godard]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Rodríguez]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Díaz]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Lera]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Salazar]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Burrows]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Valor de un test clínico para evaluar actividad física en niños]]></article-title>
<source><![CDATA[Rev Med Chil]]></source>
<year>2008</year>
<volume>136</volume>
<numero>9</numero>
<issue>9</issue>
<page-range>1155-62</page-range></nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Machado]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Gil]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Ramos]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Pírez]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Sobrepeso/obesidad en niños en edad escolar y sus factores de riesgo]]></article-title>
<source><![CDATA[Arch Pediatr Urug]]></source>
<year>2018</year>
<volume>89</volume>
<numero>^s1</numero>
<issue>^s1</issue>
<supplement>1</supplement>
<page-range>16-25</page-range></nlm-citation>
</ref>
<ref id="B21">
<label>21</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Morteo]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[El uso de psicofármacos en los centros de protección de adolescentes en Montevideo]]></article-title>
<source><![CDATA[Psicol Conoc Soc]]></source>
<year>2018</year>
<volume>8</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>84-97</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
